Aurelia Alexandru
0009-0009-1420-1034
Publication & Citation Trends
Publications
0 total
Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis
Cited by 1
Semantic Scholar
Performance of a 52-gene NGS panel combined with shallow WGS for accurate HRD analysis.
Cited by 0
Semantic Scholar
Neoadjuvant nivolumab (NIVO) + chemotherapy (chemo) vs chemo in patients (pts) with resectable NSCLC: 4-year update from CheckMate 816.
Cited by 44
Semantic Scholar
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial OA
Cited by 51
Semantic Scholar
Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial. OA
Cited by 57
Semantic Scholar
Clinical outcomes with perioperative nivolumab (NIVO) by nodal status among patients (pts) with stage III resectable NSCLC: Results from the phase 3 CheckMate 77T study.
Cited by 20
Semantic Scholar
Perioperative Nivolumab in Resectable Lung Cancer.
Cited by 307
Semantic Scholar
Systemic and intracranial outcomes with first-line nivolumab plus ipilimumab in patients with metastatic non-small cell lung cancer and baseline brain metastases from CheckMate 227 Part 1. OA
Cited by 57
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(31)
Cancer Immunotherapy and Biomarkers
(24)
Lung Cancer Diagnosis and Treatment
(18)
Lung Cancer Research Studies
(13)
Colorectal Cancer Treatments and Studies
(4)
Affiliations
Central South University
Johns Hopkins University
Ovidius University
Chinese Academy of Medical Sciences & Peking Union Medical College
University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca